HomeProductsBuilding BlocksOrganic Building BlocksBenzene CompoundsAmsilarotene
Chemical structure of CAS 125973-56-0

Amsilarotene

In Stock•Starting at $99 for 50 mg•Purity ≥ 95%
CAS No.125973-56-0
MDL No.MFCD00952173
MFC20H27NO3Si2
MW385.60
InChI KeyVVTNSTLJOVCBDL-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg95%$99In Stock
100 mg95%$155In Stock
250 mg95%$261In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.125973-56-0
Product NameAmsilarotene

Associated Conditions

hepatocellular carcinoma·liver cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine • Vol. 30, Issue 1 • 2009
PMID: 19142034DOI: 10.1159/000189712

4- [3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induced fas expression and activated caspase-3 and -8 in a DLD-1 colon cancer cell line.

In vivo (Athens, Greece) • Vol. 21, Issue 2 • 2007
PMID: 17436592

4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expression.

In vivo (Athens, Greece) • Vol. 19, Issue 1 • 2005
PMID: 15796164

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

Gynecologic oncology • Vol. 94, Issue 3 • 2004
PMID: 15350353DOI: 10.1016/j.ygyno.2004.06.026

Documentation

Similar Products